---
title: "Envoy Medical (COCH) news: delisting and Nasdaq notice"
url: "https://aibio.space/companies/envoy-medical/"
publisher: "aibio.space (Biotech Investor Relations News)"
summary: "COCH delisting and Nasdaq notice news: Envoy Medical asks Nasdaq panel to review delisting determination on market value rule. Envoy Medical, Inc."
---

COCH Envoy Medical, Inc. NASDAQ · United States

# Envoy Medical (COCH) news COCH delisting and Nasdaq notice news

Legal · 2026-10-07

## [Envoy Medical ends Atlas SPAC redemption suit in Delaware with no payment](https://aibio.space/news/envoy-medical-ends-atlas-spac-redemption-suit-delaware-no-payment/)

Atlas Merchant Capital agreed to dismiss its Chancery Court claims with prejudice, the hearing health company says. Two former executives were also named as defendants.

## Latest Envoy Medical news

1. 2025-08-29 Listings [Envoy Medical asks Nasdaq panel to review delisting determination on market value rule](https://aibio.space/news/envoy-medical-asks-nasdaq-panel-review-delisting-determination-market/) Nasdaq said Envoy did not regain compliance with its $35,000,000 market value of listed securities requirement. A hearing request filed August 29, 2025 stays any trading suspension.
2. 2025-03-03 Listings [Envoy Medical receives Nasdaq deficiency notice on $35,000,000 market value requirement](https://aibio.space/news/envoy-medical-receives-nasdaq-deficiency-notice-35-000-000-market/) Nasdaq says the market value of Envoy Medical's listed securities did not meet the minimum for 31 consecutive business days. The company has until August 25, 2025 to regain compliance.

## Envoy Medical at a glance

- **Ticker**: COCH

- **Listing**: NASDAQ

- **Country**: United States

- **Cash, Jun 30, 2026**: $19.7 million

### Related companies

- [Revium Rx.](https://aibio.space/companies/revium-rx/) OTC: RVRC
- [Twist Bioscience](https://aibio.space/companies/twist-bioscience/) NASDAQ: TWST
- [SANUWAVE Health](https://aibio.space/companies/sanuwave-health/) NASDAQ: SNWV
- [OmniAb](https://aibio.space/companies/omniab/) NASDAQ: OABI
- [iRhythm Holdings](https://aibio.space/companies/irhythm/) NASDAQ: IRTC
- [FAMILY OFFICE OF AMERICA, INC.](https://aibio.space/companies/family-office-of-america/) OTC: FOFA
- [INSULET CORP](https://aibio.space/companies/insulet/) NASDAQ: PODD
- [ENCISION INC](https://aibio.space/companies/encision/) OTC: ECIA

### Also on NASDAQ

- [BIOHARVEST SCIENCES INC.](https://aibio.space/companies/bioharvest-sciences/) BHST
- [Spyre Therapeutics](https://aibio.space/companies/spyre-therapeutics/) SYRE
- [VivoSim Labs, INC.](https://aibio.space/companies/vivosim-labs/) VIVS
- [Tectonic Therapeutic](https://aibio.space/companies/tectonic-therapeutic/) TECX
- [Jaguar Health](https://aibio.space/companies/jaguar-health/) JAGX
- [Regencell Bioscience Holdings](https://aibio.space/companies/regencell-bioscience/) RGC

## Envoy Medical annual financials

| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | [$241,000](https://www.sec.gov/Archives/edgar/data/1840877/000121390026032683/) | [$225,000](https://www.sec.gov/Archives/edgar/data/1840877/000121390026032683/) |
| Research and development | [$12.5 million](https://www.sec.gov/Archives/edgar/data/1840877/000121390026032683/) | [$10.2 million](https://www.sec.gov/Archives/edgar/data/1840877/000121390026032683/) |
| Net income (loss) | [-$23.8 million](https://www.sec.gov/Archives/edgar/data/1840877/000121390026032683/) | [-$20.8 million](https://www.sec.gov/Archives/edgar/data/1840877/000121390026032683/) |
| Cash from operations | [-$18.2 million](https://www.sec.gov/Archives/edgar/data/1840877/000121390026032683/) | [-$17.9 million](https://www.sec.gov/Archives/edgar/data/1840877/000121390026032683/) |
| Cash and equivalents | [$3.7 million](https://www.sec.gov/Archives/edgar/data/1840877/000121390026086974/) | [$5.5 million](https://www.sec.gov/Archives/edgar/data/1840877/000121390026086974/) |

Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $19.7 million.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

## Questions about Envoy Medical

Was Envoy Medical delisted?

Our latest story on this, dated Aug 29, 2025: "Envoy Medical asks Nasdaq panel to review delisting determination on market value rule". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/envoy-medical-asks-nasdaq-panel-review-delisting-determination-market/).

Has Envoy Medical received a Nasdaq deficiency notice?

Our latest story on this, dated Mar 3, 2025: "Envoy Medical receives Nasdaq deficiency notice on $35,000,000 market value requirement". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/envoy-medical-receives-nasdaq-deficiency-notice-35-000-000-market/).

What is the ticker symbol of Envoy Medical?

Envoy Medical, Inc. trades under the ticker COCH on NASDAQ.

Where is Envoy Medical listed?

Envoy Medical, Inc. is listed on NASDAQ.

Which country or territory is Envoy Medical listed under?

Our directory records Envoy Medical, Inc. under United States.

Does aibio.space cover Envoy Medical?

aibio.space lists Envoy Medical, Inc. among 2,820 public biotech companies and publishes its news here as stories appear.

What was Envoy Medical's revenue last year?

$241,000 for the fiscal year ended Dec 31, 2025, as reported to the SEC.

Is Envoy Medical profitable?

Envoy Medical, Inc. reported a net loss of $23.8 million for the fiscal year ended Dec 31, 2025, and used $18.2 million of cash in operations, per its annual report to the SEC.

How much does Envoy Medical spend on research and development?

$12.5 million in the fiscal year ended Dec 31, 2025, per its annual report.

How much cash does Envoy Medical have?

$19.7 million in cash at Jun 30, 2026, per its 10-Q.

What is the latest Envoy Medical (COCH) stock news?

Our latest story on Envoy Medical, dated Oct 7, 2026: "Envoy Medical ends Atlas SPAC redemption suit in Delaware with no payment". Atlas Merchant Capital agreed to dismiss its Chancery Court claims with prejudice, the hearing health company says. Two former executives were also named as defendants. [Source](https://aibio.space/news/envoy-medical-ends-atlas-spac-redemption-suit-delaware-no-payment/).

How long will Envoy Medical's cash last?

From our story of Oct 7, 2026: Envoy's 10-Q says its history of negative operating cash flows and losses raises substantial doubt about its ability to continue as a going concern, and that management's plans do not alleviate that doubt. [Source](https://aibio.space/news/envoy-medical-ends-atlas-spac-redemption-suit-delaware-no-payment/).

Is Envoy Medical facing a lawsuit?

Our latest legal story, dated Oct 7, 2026: "Envoy Medical ends Atlas SPAC redemption suit in Delaware with no payment". Atlas Merchant Capital agreed to dismiss its Chancery Court claims with prejudice, the hearing health company says. Two former executives were also named as defendants. Claims in lawsuits are allegations until a court rules. [Source](https://aibio.space/news/envoy-medical-ends-atlas-spac-redemption-suit-delaware-no-payment/).

How can I follow Envoy Medical (COCH) news?

Press Follow on this page to add Envoy Medical to your Following list, or subscribe to the aibio.space newsletter. We have published 3 stories naming Envoy Medical so far, in Legal, Listings.

## Investor discussion: Envoy Medical

Members talk about Envoy Medical (COCH). Reader posts, not aibio.space reporting, and not investment advice.

Rules

1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
2. **Say whether you hold the stock.** Every post states long, short or no position.
3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you.
4. **No buy or sell calls and no price targets.**
5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them.
6. **No personal details and no spam.** No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion).

## Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at Envoy Medical, newest first. Each line links the filing it comes from.

1. 2026-10-27 Listings Reported a reverse stock split. SEC Form 8-K (Items 3.03,5.03,7.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1840877/000121390026112720/ea030969601ex99-1.htm)
2. 2026-10-16 Listings Reported a shareholder vote on a reverse stock split or more authorized shares. SEC Form 8-K (Items 5.07,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1840877/000121390026110266/ea0308812-8k_envoy.htm)
3. 2026-08-31 Listings Asked shareholders to approve a reverse stock split. SEC Form DEF 14A. [Source](https://www.sec.gov/Archives/edgar/data/1840877/000121390026095756/ea0302609-02.htm)
4. 2026-08-19 Listings Asked shareholders to approve a reverse stock split. SEC Form PRE 14A. [Source](https://www.sec.gov/Archives/edgar/data/1840877/000121390026091704/ea0302609-01.htm)
5. 2026-06-30 Distress Reported the end of a material agreement. SEC Form 8-K (Items 1.02,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1840877/000121390026073659/ea029652401ex99-1.htm)
6. 2026-05-22 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 3.01). [Source](https://www.sec.gov/Archives/edgar/data/1840877/000121390026060556/ea0292043-8k_envoy.htm)

## Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:COCH on TradingView](https://www.tradingview.com/symbols/NASDAQ-COCH/).

## Listing details

Envoy Medical, Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker COCH, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

- **Company**: Envoy Medical, Inc.

- **Ticker**: COCH

- **Listing**: NASDAQ

- **Country or territory**: United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/).

Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/).

Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update)

---
Source page: https://aibio.space/companies/envoy-medical/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Envoy Medical (COCH) news: delisting and Nasdaq notice", 2026-10-31, https://aibio.space/companies/envoy-medical/